Background: There is a great variability in licit prescription drug use in the population and among patients. Factors other than purely medical ones have proven to be of importance for the prescribing of licit drugs. For example, individuals with a high age, female gender and low socioeconomic status are more likely to use licit prescription drugs. However, these results have not been adjusted for multi-morbidity level. In this study we investigate the odds of using licit prescription drugs among individuals in the population and the rate of licit prescription drug use among patients depending on gender, age and socioeconomic status after adjustment for multi-morbidity level.
Methods: The study was carried out on the total population aged 20 years or older in Östergötland county with about 400 000 inhabitants in year 2006. The Johns Hopkins ACG Case-mix was used as a proxy for the individual level of multi-morbidity in the population to which we have related the odds ratio for individuals and incidence rate ratio (IRR) for patients of using licit prescription drugs, defined daily doses (DDDs) and total costs of licit prescription drugs after adjusting for age, gender and socioeconomic factors (educational and income level).
Results: After adjustment for multi-morbidity level male individuals had less than half the odds of using licit prescription drugs (OR 0.41 (95% CI 0.40-0.42)) compared to female individuals. Among the patients, males had higher total costs (IRR 1.14 (95% CI 1.13-1.15)). Individuals above 80 years had nine times the odds of using licit prescription drugs (OR 9.09 (95% CI 8.33-10.00)) despite adjustment for multi-morbidity. Patients in the highest education and income level had the lowest DDDs (IRR 0.78 (95% CI 0.76-0.80), IRR 0.73 (95% CI 0.71-0.74)) after adjustment for multi-morbidity level.
Conclusions: This paper shows that there is a great variability in licit prescription drug use associated with gender, age and socioeconomic status, which is not dependent on level of multi-morbidity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444332 | PMC |
| http://dx.doi.org/10.1186/1471-2458-12-575 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The prevalence of selected licit and illicit drugs in drug facilitated sexual assaults.
Forensic Sci Int Synerg
July 2024
School of Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, Western Australia, 6150, Australia.
Little is known about the prevalence of incapacitating substances present in drug facilitated sexual assaults (DFSA). Presented here is a literature review conducted to provide background information, such as symptoms, exacerbations, and drug interactions, on drugs typically implicated in DFSA, namely gamma-hydroxybutyrate (GHB), gamma-butyrolactone (GBL), 1,4-butanediol (1,4-BD), ketamine, diazepam, oxycodone, methamphetamine, and alcohol. Literature found through Scopus and Pubmed was reviewed to determine the current prevalence of these substances in DFSA with a focus on Australian data.
View Article and Find Full Text PDFPrevalence of Psychoactive Substance Use During Pregnancy in Argentine Women: A Pilot Study Testing Maternal Hair.
Ther Drug Monit
August 2024
National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy .
Article Synopsis
- - The study investigated the prevalence of psychoactive substance (PS) consumption among pregnant women in Argentina by analyzing data from 51 mothers at Santa Rosa Hospital and testing their hair samples for various substances.
- - Results revealed high rates of alcohol (49%), tobacco (25.5%), and cannabis use (23.5%), with 56.9% of participants testing positive for illicit substances, notably cocaine (41.2%).
- - This research is significant as it uniquely highlights cocaine as the most common illicit PS among pregnant women in the region, stressing the need for ongoing tracking of PS use trends during pregnancy in Argentina.
Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada.
Drug Alcohol Rev
November 2024
British Columbia Centre on Substance Use, Vancouver, Canada.
Article Synopsis
- The study focuses on rising methamphetamine/amphetamine use among individuals with prescription-type opioid use disorder (POUD) in North America, particularly those starting treatments like methadone or buprenorphine/naloxone.
- Using logistic regression, the research examined factors linked to methamphetamine use in a sample of 269 participants, finding significant correlations with positive fentanyl tests, recent non-fatal overdoses, and previous opioid treatment exposure.
- The findings highlight the connection between methamphetamine use and severe opioid use disorder markers, indicating a need for targeted interventions to improve treatment and reduce overdose risks in this vulnerable population.
Sexually transmitted and blood-borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: Findings from a Canadian pragmatic randomized trial.
HIV Med
July 2024
Research Centre, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Introduction: People who use drugs are disproportionally affected by sexually transmitted and blood-borne infections (STBBIs). While the benefits of methadone in reducing injecting-risk behaviours are well documented, less is known on its impacts on sexual-related risks, as well as its comparative effectiveness to buprenorphine/naloxone, particularly in the context of highly potent opioids. The aim of this study was to estimate the relative effects of buprenorphine/naloxone and methadone on injecting and STBBI risks among people with prescription-type opioid use disorder (POUD).
View Article and Find Full Text PDFComprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy.
Ther Drug Monit
April 2024
Department of Mental Health, Azienda Sanitaria Locale (ASL) Roma 1-Servizio Psichiatrico di Diagnosi e Cura (SPDC), San Filippo Neri Hospital, Rome, Italy.
Background: The comprehensive monitoring of licit and illicit drug consumption plays a crucial role in understanding the complexities of patient conditions and designing effective treatment strategies. In this study, the prevalence of psychoactive prescription drugs, classical illicit drugs, and new psychoactive substances (NPS) were objectively assessed in individuals diagnosed with drug-related psychiatric disorders or episodes.
Methods: Blood, urine, and hair samples were collected from psychiatric patients admitted to the Mental Health Department and Drug Addiction Service of the North Rome Local Health Authority with declared or suspected psychoactive drug use.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!